Hetarylfuroxans: cytotoxic effect and induction of apoptosis in chronic myeloid leukemia K562 cells

被引：8
|
作者：
Pukhov, S. A. [1 ]
Anikina, L. A. [1 ]
Larin, A. A. [2 ]
Fershtat, L. L. [2 ]
Kulikov, A. S. [2 ]
Makhova, N. N. [2 ]
机构：
[1] Russian Acad Sci, Inst Physiol Act Cpds, 1 Severnyi Proezd, Chernogolovka 142432, Moscow Region, Russia
[2] Russian Acad Sci, ND Zelinsky Inst Organ Chem, 47 Leninsky Prosp, Moscow 119991, Russia
来源：
RUSSIAN CHEMICAL BULLETIN | 2019年 / 68卷 / 01期
基金：
俄罗斯基础研究基金会;
关键词：
cytotoxicity; chronic myeloid leukemia K562; hetarylfuroxans; apoptosis; caspase-3; caspase-7; ANTIAGGREGANT ACTIVITY; TYROSINE KINASE; INHIBITORS; FUROXANS; SYSTEMS; EVENTS; DESIGN;
D O I：
10.1007/s11172-019-2431-5
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
Hetarylfuroxans (4-(2-methylpyridin-5-yloxy)-3-phenylfuroxan (1), bis(1,2,4-oxadiazol-3-yl)furoxan (2), and 4-amino-3-(indenotriazin-3-yl)furoxan (3)) exhibit in vitro cytotoxic activity against chronic myeloid leukemia K562 cells. All studied furoxans induce apoptosis in K562 cells. The experiments with activation of caspases-3 and -7 showed that furoxan 3 possessed the highest apoptosis-inducing capacity. The studied hetarylfuroxans were found to be the promising drug candidates for the treatment of chronic myeloid leukemia K562.
引用
收藏
页码：158 / 162
页数：5
相关论文
共 50 条
  • [41] PaDef defensin from avocado (Persea americana var. drymifolia) is cytotoxic to K562 chronic myeloid leukemia cells through extrinsic apoptosis
    Jose Flores-Alvarez, Luis
    Julia Guzman-Rodriguez, Jaquelina
    Lopez-Gomez, Rodolfo
    Salgado-Garciglia, Rafael
    Ochoa-Zarzosa, Alejandra
    Lopez-Meza, Joel E.
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2018, 99 : 10 - 18
  • [42] The K562 chronic myeloid leukemia cell line undergoes apoptosis in response to interferon-α
    Luchetti, F
    Gregorini, A
    Papa, S
    Burattini, S
    Canonico, B
    Valentini, M
    Falcieri, E
    [J]. HAEMATOLOGICA, 1998, 83 (11) : 974 - 980
  • [43] Effect of cortisol on K562 leukemia cells
    Fonseca, Marcelo de Oliveira
    da Silva, Newton Soares
    Soares, Cristina Pacheco
    [J]. MUNDO DA SAUDE, 2019, 43 (04): : 854 - 861
  • [44] DNA damage response in imatinib resistant chronic myeloid leukemia K562 cells
    Dinis, Joana
    Silva, Vania
    Gromicho, Marta
    Martins, Celia
    Laires, Antonio
    Tavares, Purificacao
    Rendeiro, Paula
    Torres, Fatima
    Rueff, Jose
    Rodrigues, Antonio
    [J]. LEUKEMIA & LYMPHOMA, 2012, 53 (10) : 2004 - 2014
  • [45] Caspase-independent apoptosis induction of quorum-sensing autoinducer analogs against chronic myeloid leukemia K562
    Masaharu Hazawa
    Michiko Kudo
    Toshihiro Iwata
    Kazuki Saito
    Kenji Takahashi
    Jun Igarashi
    Hiroaki Suga
    Ikuo Kashiwakura
    [J]. Investigational New Drugs, 2012, 30 : 862 - 869
  • [46] Caspase-independent apoptosis induction of quorum-sensing autoinducer analogs against chronic myeloid leukemia K562
    Hazawa, Masaharu
    Kudo, Michiko
    Iwata, Toshihiro
    Saito, Kazuki
    Takahashi, Kenji
    Igarashi, Jun
    Suga, Hiroaki
    Kashiwakura, Ikuo
    [J]. INVESTIGATIONAL NEW DRUGS, 2012, 30 (03) : 862 - 869
  • [47] Dihydroartemisinin downregulates vascular endothelial growth factor expression and induces apoptosis in chronic myeloid leukemia K562 cells
    Jun Lee
    Hui-Jun Zhou
    Xiu-Hua Wu
    [J]. Cancer Chemotherapy and Pharmacology, 2006, 57 : 213 - 220
  • [48] Resveratrol Triggers Apoptosis Through Regulating Ceramide Metabolizing Genes in Human K562 Chronic Myeloid Leukemia Cells
    Kartal, Melis
    Saydam, Guray
    Sahin, Fahri
    Baran, Yusuf
    [J]. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2011, 63 (04): : 637 - 644
  • [49] Effect of matrine on autophagy and apoptosis of human leukemia K562/IM cells
    胡美薇
    [J]. China Medical Abstracts (Internal Medicine), 2018, 35 (02) : 74 - 75
  • [50] Dihydroartemisinin downregulates vascular endothelial growth factor expression and induces apoptosis in chronic myeloid leukemia K562 cells
    Lee, J
    Zhou, HJ
    Wu, XH
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (02) : 213 - 220
12345